Defective Cyclic Guanosine Monophosphate-gated Calcium Channels and the Pathogenesis of Psoriasis

Acta Dermato-Venereologica

Volumn 83, Issue 6, 2003, Pages 414-418

  McKenzie, Roddie C ^a,d   Oda, Yuko ^b   Szepietowski, Jacek C ^c   Behne, Martin J ^b   Mauro, Theodora ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WROCLAW MEDICAL UNIVERSITY   (Poland)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Calcium; Calcium channel; Cyclic guanosine monophosphate (cGMP); Differentiation; Keratinocyte; Psoriasis

Indexed keywords

CALCIUM CHANNEL; CYCLIC GMP; MESSENGER RNA;

ADULT; AGED; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DNA SPLICING; EMBRYO; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS;

ADULT; AGED; BIOPSY, NEEDLE; CALCIUM CHANNELS; CALCIUM SIGNALING; CASE-CONTROL STUDIES; CELLS, CULTURED; CYCLIC GMP; FEMALE; GENETIC MARKERS; HUMANS; IMMUNOHISTOCHEMISTRY; ION CHANNEL GATING; KERATINOCYTES; MALE; MIDDLE AGED; PROBABILITY; PSORIASIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RNA, MESSENGER; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 0345258018     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/00015550310014726     Document Type: Article

References (17)

1. Cohen AD, Kagen M, Friger M, Halevy S. Calcium channel blockers intake and psoriasis: a case controlled study. Acta Derm Venereol 2001; 81: 347-349.
2. Karvonen S-L, Korkiamaki T, Yla-Outinen H, Nissinen M, Teerikangas H, Pummi K, et al. Psoriasis and altered calcium metabolism: downregulated capacitative calcium influx and defective calcium-mediated cell signalling in cultured psoriatic keratinocytes. J Invest Dermatol 2000; 114: 693-700.
3. Jones KT, Sharpe GR. Proliferating cell nuclear antigen decreases in normal human keratinocytes with differentiation stimuli but not in an HPV immortalized cell-line. Acta Derm Venereol 1994; 74: 241-244.
4. Reiss M, Lipsey LR, Zhou ZL. Extracellular calcium-dependent regulation of transmembrane calcium fluxes in murine keratinocytes. J Cell Physiol 1991; 147: 281-289.
5. 2+ in the 2nd stage. J Biol Chem 1993; 268: 25139-25145.
6. Lee SH, Elias PM, Feingold KR, Mauro T. A role for ions in barrier recovery after acute perturbation. J Invest Dermatol 1994; 102: 976-979.
7. 2+-induced differentiation. J Invest Dermatol 1997; 106: 864-870.
8. Oda Y, Timpe LC, McKenzie RC, Sauder DN, Largman C, Mauro T. Alternatively spliced forms of the cGMP-gated channel in human keratinocytes. FEBS Letts 1997; 414: 140-145.
9. Oda Y, Tu CL, Chang WH, Crumrine D, Komuves L, Mauro T, et al. The calcium sensing receptor and its alternatively spliced form in murine epidermal differentiation. J Biol Chem 2000; 275: 1183-1190.
10. Szepietowski JC, Walker C, Hunter JAA, McKenzie RC. Elevated leukaemia inhibitory factor in lesional psoriatic skin: correlation with interleukin-8 expression. J Dermatol 2001; 28: 115-122.
11. Jackson M, Howie SEM, Weller R, Hunter JAA, McKenzie RC. Psoriatic keratinocytes show reduced IRF-1 and STAT-1 alpha activation in response to gamma-IFN. FASEB J 1999; 13: 495-502.
12. Kondo S, Kono T, Sauder DN, McKenzie RC. IL-8 gene expression and production in human keratinocytes and their modulation by UVB. J Invest Dermatol 1993; 101: 690-694.
13. Törmä H, Karlsson T, Michaesson G, Rollman O, Vahlquist A. Decreased mRNA levels of retinoic acid receptor α, retinoid X receptor α and thyroid hormone receptor α in lesional psoriatic skin. Acta Derm Venereol 2000; 80: 4-9.
14. Menon GK, Elias PM. Ultrastructural-localisation of calcium in psoriatic and normal human epidermis. Arch Dermatol 1991; 127: 57-63.
15. Sabin L, Weller R, Howie SEM, McKenzie RC. Supranormal nitric oxide (NO) production and subnormal NFκB activity in keratinocytes (KC) from psoriatic patients. Br J Dermatol 2001; 44: 659.
16. Weller R, Ormerod A. Increased expression of inducible nitric oxide (NO) synthase. Br J Dermatol 1997; 136: 136-137.
17. McKenzie RC, Weller R. Langerhans cells, keratinocytes, nitric oxide and psoriasis. Immunol Today 1998; 19: 427-428.